Mara Aspinall joins Castle Biosciences, Inc. Board of Directors

Posted on Tue/24/FebruaryTue/24/February by AZBio

Castle Biosciences Announces New Director Appointment and CFO Hire

Dan Hudspeth Joins SynCardia Systems, Inc. As Chief Financial Officer

Posted on Tue/24/FebruaryTue/24/February by AZBio

Dan Hudspeth has been named Chief Financial Officer of SynCardia Systems, Inc., the company announced on JUly 24, 2015.Continue reading→

Economic Impact of the Proposed $1B in Expanded University Research Infrastructure

Posted on Sun/22/FebruaryThu/26/July by AZBio

Lasting economic impact, the kind that spans generations and creates jobs today and in the future depends on a series of strategic investments and commitments made by both the public sector and the private sectors.Continue reading→

UA Arthritis Center Receives $6.1 Million 5-Year NIH Grant to Help Identify Treatments for Osteoarthritis

Posted on Wed/11/FebruaryMon/16/February by AZBio

Osteoarthritis (OA) is the most common cause of disability in the aging population, and the public health impact of knee OA, in particular, is expected to increase dramatically. The UA research will help identify potential targets to prevent the development or halt the progression of the condition.
Continue reading→

The BIO International Convention Sweetheart Deal

Posted on Tue/10/FebruarySat/14/February by AZBio

Learn how you can save BIG on Convention Registration in February!Continue reading→

Digital Magazine Video Features SynCardia Total Artificial Heart

Posted on Tue/10/FebruarySat/14/February by AZBio

The winter 2015 HP Matter issue on health care technology features a 3:35 video of two Arizona men who were implanted with the SynCardia Total Artificial Heart.Continue reading→

UA in The Spotlight: Never Settle

Posted on Sun/8/FebruarySat/14/February by AZBio

In the first progress report to the Arizona Board of Regents on the strategic plan, UA President Ann Weaver Hart highlights major achievements in student success, research and economic development. (see full article)Continue reading→

EUROPEAN MEDICINES AGENCY QUALIFIES ‘HOLLOW FIBER SYSTEM’ FOR ANTI-TUBERCULOSIS DRUG DEVELOPMENT

Posted on Fri/6/FebruarySat/14/February by AZBio

Provides major boost for improved development of TB treatment to meet major public health challengeContinue reading→

CBR Establishes Medical Advisory Board Composed of Internationally Renowned Stem Cell Expert

Posted on Tue/3/FebruaryWed/11/March by AZBio

Cord Blood Registry® (CBR®) announces the establishment of a Scientific and Medical Advisory Board (SMAB). Composed of internationally renowned stem cell experts, the SMAB will provide input and guidance to help advance CBR’s mission to expand the scope of newborn stem cell therapies that may be available to patients and their families.Continue reading→